U.S. Markets open in 1 hr 8 mins

CLASS ACTION UPDATE for UXIN, DPLO and CRCM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / April 11, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided.

Uxin Limited (UXIN)

Class Period: Pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the June 27, 2018 initial public offering
Lead Plaintiff Deadline : April 12, 2019
Join the action: https://www.zlk.com/pslra-1/uxin-limited-loss-form?prid=1042&wire=1

The Registration Statement was materially false and misleading and omitted to state that: (1) Uxin was likely to stop providing complementary services such as inspections to its customers; (2) instead, Uxin would connect consumers to dealers who would provide such complementary services; (3) as a result, Uxin's 2B business would be materially impacted; and (4) consequently, Defendants' statements in the Registration Statement regarding Uxin's business, operations, and prospects, were materially false and/or misleading.

To learn more about the Uxin Limited class action contact jlevi@levikorsinsky.com.

Diplomat Pharmacy, Inc. (DPLO)

Class Period: February 26, 2018 - February 21, 2019
Lead Plaintiff Deadline : April 25, 2019
Join the action: https://www.zlk.com/pslra-1/diplomat-pharmacy-inc-loss-form?prid=1042&wire=1

The lawsuit alleges: Diplomat Pharmacy, Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (1) Diplomat had downplayed its success in integrating and growing its PBM business, which included LDI Integrated and National Pharmaceutical, two companies Diplomat had acquired in late 2017; (2) consequently, Diplomat would need to record a non-cash impairment charge upwards of approximately $630 million relating to its PBM business and these 2017 acquisitions; (3) due to the foregoing, Diplomat would withdraw its preliminary 2019 full-year outlook issued less than seven weeks prior; and (4) as a result, defendants' statements about Diplomat's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To learn more about the Diplomat Pharmacy, Inc. class action contact jlevi@levikorsinsky.com.

Care.com, Inc. (CRCM)

Class Period: March 27, 2015 - April 1, 2019
Lead Plaintiff Deadline : June 3, 2019
Join the action: https://www.zlk.com/pslra-1/care-com-inc-loss-form?prid=1042&wire=1

The complaint alleges that Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts, with respect to the manner in which the Company vets the caregivers and daycare providers listed on its website.

To learn more about the Care.com, Inc. class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/541757/CLASS-ACTION-UPDATE-for-UXIN-DPLO-and-CRCM-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders